{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:29:45Z","timestamp":1759588185502},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,9,19]],"date-time":"2008-09-19T00:00:00Z","timestamp":1221782400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1007\/s10549-008-0186-z","type":"journal-article","created":{"date-parts":[[2008,9,18]],"date-time":"2008-09-18T17:30:45Z","timestamp":1221759045000},"page":"243-251","source":"Crossref","is-referenced-by-count":27,"title":["Post-transcriptional regulation of chemokine receptor CXCR4 by estrogen in HER2 overexpressing, estrogen receptor-positive breast cancer cells"],"prefix":"10.1007","volume":"117","author":[{"given":"Surojeet","family":"Sengupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Schiff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benita S.","family":"Katzenellenbogen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,9,19]]},"reference":[{"key":"186_CR1","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/35065016","volume":"410","author":"A Muller","year":"2001","unstructured":"Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME et al (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410:50\u201356. doi: 10.1038\/35065016","journal-title":"Nature"},{"key":"186_CR2","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/jnci\/95.2.142","volume":"95","author":"G Konecny","year":"2003","unstructured":"Konecny G, Pauletti G, Pegram M, Untch M, Dandekar S, Aguilar Z et al (2003) Quantitative association between HER-2\/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer. J Natl Cancer Inst 95:142\u2013153","journal-title":"J Natl Cancer Inst"},{"key":"186_CR3","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1126\/science.3798106","volume":"235","author":"DJ Slamon","year":"1987","unstructured":"Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2\/neu oncogene. Science 235:177\u2013182. doi: 10.1126\/science.3798106","journal-title":"Science"},{"key":"186_CR4","doi-asserted-by":"crossref","first-page":"6115","DOI":"10.1038\/sj.onc.1203972","volume":"19","author":"D Yu","year":"2000","unstructured":"Yu D, Hung MC (2000) Overexpression of ErbB2 in cancer and ErbB2-targeting strategies. Oncogene 19:6115\u20136121. doi: 10.1038\/sj.onc.1203972","journal-title":"Oncogene"},{"key":"186_CR5","first-page":"4801","volume":"63","author":"Y Chen","year":"2003","unstructured":"Chen Y, Stamatoyannopoulos G, Song CZ (2003) Down-regulation of CXCR4 by inducible small interfering RNA inhibits breast cancer cell invasion in\u00a0vitro. Cancer Res 63:4801\u20134804","journal-title":"Cancer Res"},{"key":"186_CR6","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/sj.cgt.7700770","volume":"12","author":"N Lapteva","year":"2005","unstructured":"Lapteva N, Yang AG, Sanders DE, Strube RW, Chen SY (2005) CXCR4 knockdown by small interfering RNA abrogates breast tumor growth in\u00a0vivo. Cancer Gene Ther 12:84\u201389. doi: 10.1038\/sj.cgt.7700770","journal-title":"Cancer Gene Ther"},{"key":"186_CR7","doi-asserted-by":"crossref","first-page":"8604","DOI":"10.1158\/0008-5472.CAN-04-1844","volume":"64","author":"MC Smith","year":"2004","unstructured":"Smith MC, Luker KE, Garbow JR, Prior JL, Jackson E, Piwnica-Worms D et al (2004) CXCR4 regulates growth of both primary and metastatic breast cancer. Cancer Res 64:8604\u20138612. doi: 10.1158\/0008-5472.CAN-04-1844","journal-title":"Cancer Res"},{"key":"186_CR8","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1158\/0008-5472.CAN-03-3958","volume":"64","author":"Z Liang","year":"2004","unstructured":"Liang Z, Wu T, Lou H, Yu X, Taichman RS, Lau SK et al (2004) Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4. Cancer Res 64:4302\u20134308. doi: 10.1158\/0008-5472.CAN-03-3958","journal-title":"Cancer Res"},{"key":"186_CR9","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1158\/0008-5472.967.65.3","volume":"65","author":"Z Liang","year":"2005","unstructured":"Liang Z, Yoon Y, Votaw J, Goodman MM, Williams L, Shim H (2005) Silencing of CXCR4 blocks breast cancer metastasis. Cancer Res 65:967\u2013971","journal-title":"Cancer Res"},{"key":"186_CR10","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1535-6108(03)00132-6","volume":"3","author":"Y Kang","year":"2003","unstructured":"Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, Cordon-Cardo C et al (2003) A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3:537\u2013549. doi: 10.1016\/S1535-6108(03)00132-6","journal-title":"Cancer Cell"},{"key":"186_CR11","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nature03799","volume":"436","author":"AJ Minn","year":"2005","unstructured":"Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD et al (2005) Genes that mediate breast cancer metastasis to lung. Nature 436:518\u2013524. doi: 10.1038\/nature03799","journal-title":"Nature"},{"key":"186_CR12","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s10549-005-9121-8","volume":"97","author":"O Salvucci","year":"2006","unstructured":"Salvucci O, Bouchard A, Baccarelli A, Deschenes J, Sauter G, Simon R et al (2006) The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study. Breast Cancer Res Treat 97:275\u2013283. doi: 10.1007\/s10549-005-9121-8","journal-title":"Breast Cancer Res Treat"},{"key":"186_CR13","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1056\/NEJM200103153441101","volume":"344","author":"DJ Slamon","year":"2001","unstructured":"Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A et al (2001) Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 344:783\u2013792. doi: 10.1056\/NEJM200103153441101","journal-title":"N Engl J Med"},{"key":"186_CR14","first-page":"3947","volume":"50","author":"LD Read","year":"1990","unstructured":"Read LD, Keith D Jr, Slamon DJ, Katzenellenbogen BS (1990) Hormonal modulation of HER-2\/neu protooncogene messenger ribonucleic acid and p185 protein expression in human breast cancer cell lines. Cancer Res 50:3947\u20133951","journal-title":"Cancer Res"},{"key":"186_CR15","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1309\/YMJ3A83TB39MRUT9","volume":"123","author":"P Lal","year":"2005","unstructured":"Lal P, Tan LK, Chen B (2005) Correlation of HER-2 status with estrogen and progesterone receptors and histologic features in 3, 655 invasive breast carcinomas. Am J Clin Pathol 123:541\u2013546. doi: 10.1309\/YMJ3A83TB39MRUT9","journal-title":"Am J Clin Pathol"},{"key":"186_CR16","doi-asserted-by":"crossref","first-page":"865s","DOI":"10.1158\/1078-0432.865s.11.2","volume":"11","author":"CK Osborne","year":"2005","unstructured":"Osborne CK, Shou J, Massarweh S, Schiff R (2005) Crosstalk between estrogen receptor and growth factor receptor pathways as a cause for endocrine therapy resistance in breast cancer. Clin Cancer Res 11:865s\u2013870s","journal-title":"Clin Cancer Res"},{"key":"186_CR17","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF01961241","volume":"24","author":"CC Benz","year":"1992","unstructured":"Benz CC, Scott GK, Sarup JC, Johnson RM, Tripathy D, Coronado E et al (1992) Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2\/neu. Breast Cancer Res Treat 24:85\u201395. doi: 10.1007\/BF01961241","journal-title":"Breast Cancer Res Treat"},{"key":"186_CR18","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ccr.2004.09.027","volume":"6","author":"YM Li","year":"2004","unstructured":"Li YM, Pan Y, Wei Y, Cheng X, Zhou BP, Tan M et al (2004) Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis. Cancer Cell 6:459\u2013469. doi: 10.1016\/j.ccr.2004.09.027","journal-title":"Cancer Cell"},{"key":"186_CR19","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.1210\/en.2003-0567","volume":"144","author":"J Frasor","year":"2003","unstructured":"Frasor J, Danes JM, Komm B, Chang KC, Lyttle CR, Katzenellenbogen BS (2003) Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology 144:4562\u20134574. doi: 10.1210\/en.2003-0567","journal-title":"Endocrinology"},{"key":"186_CR20","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/jnci\/djh166","volume":"96","author":"J Shou","year":"2004","unstructured":"Shou J, Massarweh S, Osborne CK, Wakeling AE, Ali S, Weiss H et al (2004) Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2\/neu cross-talk in ER\/HER2-positive breast cancer. J Natl Cancer Inst 96:926\u2013935","journal-title":"J Natl Cancer Inst"},{"key":"186_CR21","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402\u2013408","journal-title":"Methods"},{"key":"186_CR22","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nrd1134","volume":"2","author":"E Clercq De","year":"2003","unstructured":"De Clercq E (2003) The bicyclam AMD3100 story. Nat Rev Drug Discov 2:581\u2013587. doi: 10.1038\/nrd1134","journal-title":"Nat Rev Drug Discov"},{"key":"186_CR23","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.cell.2005.02.031","volume":"121","author":"L Ma","year":"2005","unstructured":"Ma L, Chen Z, Erdjument-Bromage H, Tempst P, Pandolfi PP (2005) Phosphorylation and functional inactivation of TSC2 by Erk: implications for tuberous sclerosis and cancer pathogenesis. Cell 121:179\u2013193. doi: 10.1016\/j.cell.2005.02.031","journal-title":"Cell"},{"key":"186_CR24","first-page":"1238","volume":"48","author":"MS Berger","year":"1988","unstructured":"Berger MS, Locher GW, Saurer S, Gullick WJ, Waterfield MD, Groner B et al (1988) Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading. Cancer Res 48:1238\u20131243","journal-title":"Cancer Res"},{"key":"186_CR25","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jsbmb.2005.07.002","volume":"98","author":"FE Gago","year":"2006","unstructured":"Gago FE, Fanelli MA, Ciocca DR (2006) Co-expression of steroid hormone receptors (estrogen receptor alpha and\/or progesterone receptors) and Her2\/neu (c-erbB-2) in breast cancer: clinical outcome following tamoxifen-based adjuvant therapy. J Steroid Biochem Mol Biol 98:36\u201340. doi: 10.1016\/j.jsbmb.2005.07.002","journal-title":"J Steroid Biochem Mol Biol"},{"key":"186_CR26","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/ng1901","volume":"38","author":"JS Carroll","year":"2006","unstructured":"Carroll JS, Meyer CA, Song J, Li W, Geistlinger TR, Eeckhoute J et al (2006) Genome-wide analysis of estrogen receptor binding sites. Nat Genet 38:1289\u20131297. doi: 10.1038\/ng1901","journal-title":"Nat Genet"},{"key":"186_CR27","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1158\/0008-5472.CAN-03-3326","volume":"64","author":"J Frasor","year":"2004","unstructured":"Frasor J, Stossi F, Danes JM, Komm B, Lyttle CR, Katzenellenbogen BS (2004) Selective estrogen receptor modulators: Discrimination of agonistic versus antagonistic activities by gene expression profiling in breast cancer cells. Cancer Res 64:1522\u20131533. doi: 10.1158\/0008-5472.CAN-03-3326","journal-title":"Cancer Res"},{"key":"186_CR28","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/nrc2211","volume":"7","author":"KA Green","year":"2007","unstructured":"Green KA, Carroll JS (2007) Oestrogen-receptor-mediated transcription and the influence of co-factors and chromatin state. Nat Rev Cancer 7:713\u2013722. doi: 10.1038\/nrc2211","journal-title":"Nat Rev Cancer"},{"key":"186_CR29","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1371\/journal.pgen.0030087","volume":"3","author":"CY Lin","year":"2007","unstructured":"Lin CY, Vega VB, Thomsen JS, Zhang T, Kong SL, Xie M et al (2007) Whole-genome cartography of estrogen receptor alpha binding sites. PLoS Genet 3:e87. doi: 10.1371\/journal.pgen.0030087","journal-title":"PLoS Genet"},{"key":"186_CR30","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1158\/0008-5472.CAN-07-6151","volume":"68","author":"DH Barnett","year":"2008","unstructured":"Barnett DH, Sheng S, Howe Charn T, Waheed A, Sly WS, Lin C-Y et al (2008) Estrogen receptor regulation of carbonic anhydrase XII through a distal enhancer in breast cancer. Cancer Res 68:3505\u20133515. doi: 10.1158\/0008-5472.CAN-07-6151","journal-title":"Cancer Res"},{"key":"186_CR31","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1053\/j.seminoncol.2004.01.004","volume":"31","author":"BS Katzenellenbogen","year":"2004","unstructured":"Katzenellenbogen BS, Frasor J (2004) Therapeutic targeting in the estrogen receptor hormonal pathway. Semin Oncol 31:28\u201338. doi: 10.1053\/j.seminoncol.2004.01.004","journal-title":"Semin Oncol"},{"key":"186_CR32","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1210\/me.2005-0186","volume":"20","author":"WR Harrington","year":"2006","unstructured":"Harrington WR, Kim SH, Funk CC, Madak-Erdogan Z, Schiff R, Katzenellenbogen JA et al (2006) Estrogen dendrimer conjugates that preferentially activate extranuclear, nongenomic versus genomic pathways of estrogen action. Mol Endocrinol 20:491\u2013502. doi: 10.1210\/me.2005-0186","journal-title":"Mol Endocrinol"},{"key":"186_CR33","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1210\/me.2008-0059","volume":"22","author":"Z Madak-Erdogan","year":"2008","unstructured":"Madak-Erdogan Z, Kieser KJ, Kim SH, Komm B, Katzenellenbogen JA, Katzenellenbogen BS (2008) Nuclear and extranuclear pathway inputs in the regulation of global gene expression by estrogen receptors. Mol Endocrinol 22:2116\u20132127. doi: 10.1210\/me.2008-0059","journal-title":"Mol Endocrinol"},{"key":"186_CR34","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1158\/1078-0432.CCR-06-2540","volume":"13","author":"S Massarweh","year":"2007","unstructured":"Massarweh S, Schiff R (2007) Unraveling the mechanisms of endocrine resistance in breast cancer: new therapeutic opportunities. Clin Cancer Res 13:1950\u20131954. doi: 10.1158\/1078-0432.CCR-06-2540","journal-title":"Clin Cancer Res"},{"key":"186_CR35","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1200\/JCO.2005.10.036","volume":"23","author":"CK Osborne","year":"2005","unstructured":"Osborne CK, Schiff R (2005) Estrogen-receptor biology: continuing progress and therapeutic implications. J Clin Oncol 23:1616\u20131622. doi: 10.1200\/JCO.2005.10.036","journal-title":"J Clin Oncol"},{"key":"186_CR36","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.1158\/1078-0432.CCR-07-1373","volume":"13","author":"RJ Pietras","year":"2007","unstructured":"Pietras RJ, Marquez-Garban DC (2007) Membrane-associated estrogen receptor signaling pathways in human cancers. Clin Cancer Res 13:4672\u20134676. doi: 10.1158\/1078-0432.CCR-07-1373","journal-title":"Clin Cancer Res"},{"key":"186_CR37","doi-asserted-by":"crossref","first-page":"R144","DOI":"10.1186\/bcr627","volume":"5","author":"M Kato","year":"2003","unstructured":"Kato M, Kitayama J, Kazama S, Nagawa H (2003) Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma. Breast Cancer Res 5:R144\u2013R150. doi: 10.1186\/bcr627","journal-title":"Breast Cancer Res"},{"key":"186_CR38","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0092-8674(04)00115-1","volume":"116","author":"RJ Kelleher 3rd","year":"2004","unstructured":"Kelleher RJ 3rd, Govindarajan A, Jung HY, Kang H, Tonegawa S (2004) Translational control by MAPK signaling in long-term synaptic plasticity and memory. Cell 116:467\u2013479. doi: 10.1016\/S0092-8674(04)00115-1","journal-title":"Cell"},{"key":"186_CR39","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10549-005-1483-4","volume":"92","author":"JM Rae","year":"2005","unstructured":"Rae JM, Johnson MD, Scheys JO, Cordero KE, Larios JM, Lippman ME (2005) GREB1 is a critical regulator of hormone dependent breast cancer growth. Breast Cancer Res Treat 92:141\u2013149. doi: 10.1007\/s10549-005-1483-4","journal-title":"Breast Cancer Res Treat"},{"key":"186_CR40","doi-asserted-by":"crossref","first-page":"7475","DOI":"10.1038\/sj.onc.1209090","volume":"24","author":"A Astrinidis","year":"2005","unstructured":"Astrinidis A, Henske EP (2005) Tuberous sclerosis complex: linking growth and energy signaling pathways with human disease. Oncogene 24:7475\u20137481. doi: 10.1038\/sj.onc.1209090","journal-title":"Oncogene"},{"key":"186_CR41","doi-asserted-by":"crossref","first-page":"8266","DOI":"10.1158\/0008-5472.CAN-05-4045","volume":"66","author":"S Massarweh","year":"2006","unstructured":"Massarweh S, Osborne CK, Jiang S, Wakeling AE, Rimawi M, Mohsin SK et al (2006) Mechanisms of tumor regression and resistance to estrogen deprivation and fulvestrant in a model of estrogen receptor-positive, HER-2\/neu-positive breast cancer. Cancer Res 66:8266\u20138273. doi: 10.1158\/0008-5472.CAN-05-4045","journal-title":"Cancer Res"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-008-0186-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-008-0186-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-008-0186-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T00:25:40Z","timestamp":1684542340000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-008-0186-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9,19]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["186"],"URL":"https:\/\/doi.org\/10.1007\/s10549-008-0186-z","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9,19]]}}}